Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet… - … in medical oncology, 2020 - journals.sagepub.com
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
[PDF][PDF] Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet, FC Kuan… - 2020 - pdfs.semanticscholar.org
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet, FC Kuan… - THERAPEUTIC …, 2020 - flore.unifi.it
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer.
F Loupakis, L Antonuzzo, JB Bachet… - … Advances in Medical …, 2020 - europepmc.org
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo… - Therapeutic …, 2020 - mayoclinic.elsevierpure.com
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer.
F Loupakis, L Antonuzzo, JB Bachet… - Therapeutic …, 2020 - search.ebscohost.com
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
[HTML][HTML] Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet… - … Advances in Medical …, 2020 - ncbi.nlm.nih.gov
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet… - Therapeutic …, 2020 - pubmed.ncbi.nlm.nih.gov
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet… - Therapeutic …, 2020 - hal.sorbonne-universite.fr
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …
Practical considerations in the use of regorafenib in metastatic colorectal cancer
F Loupakis, L Antonuzzo, JB Bachet, FC Kuan… - … Advances in Medical …, 2020 - hal.science
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC)
has improved considerably, leading to increased overall survival and more patients eligible …
has improved considerably, leading to increased overall survival and more patients eligible …